[Molecular pathology for breast cancer: Importance of the gene expression profile].

about

Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer An international comparability study on quantification of mRNA gene expression ratios: CCQM-P103.1.Eugenol alleviated breast precancerous lesions through HER2/PI3K-AKT pathway-induced cell apoptosis and S-phase arrest.

P2860

Q26745446-E17A33E2-18CF-4ADB-8B80-FBBDDC7E422B Q37000029-1A38157C-099A-4494-9D8C-03B86ED11D35 Q41346977-36D52A86-D504-49C9-ADF2-296FFEE866ED

P2860

[Molecular pathology for breast cancer: Importance of the gene expression profile].

Item

http://www.wikidata.org/entity/Q52868166

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

[Molecular pathology for breast cancer: Importance of the gene expression profile].

@en

[Molecular pathology for breast cancer: Importance of the gene expression profile].

@nl

type

Item

label

[Molecular pathology for breast cancer: Importance of the gene expression profile].

@en

[Molecular pathology for breast cancer: Importance of the gene expression profile].

@nl

prefLabel

[Molecular pathology for breast cancer: Importance of the gene expression profile].

@en

[Molecular pathology for breast cancer: Importance of the gene expression profile].

@nl

P1476

[Molecular pathology for breast cancer: Importance of the gene expression profile].

@en

P2093

B I Heppner

http://www.w3.org/2001/XMLSchema#string

B M Pfitzner

http://www.w3.org/2001/XMLSchema#string

M Dietel

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer

Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Clinical application of the 70-gene profile: the MINDACT trial

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Supervised risk predictor of breast cancer based on intrinsic subtypes

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

P2888

s00292-015-0009-z

P304

145-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00292-015-0009-Z

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carsten Denkert

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25836324

http://www.w3.org/2001/XMLSchema#string

[Molecular pathology for breast cancer: Importance of the gene expression profile].

about

P2860

P2860

[Molecular pathology for breast cancer: Importance of the gene expression profile].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698